Healthcare & Medical Devices Global On demand · 24-48h

Global Blood Grouping Gel Card Market Strategic Research Report

Global Blood Grouping Gel Card Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Blood Grouping Gel Card Market
$77.282025
7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Six Columns, Eight Columns

By Application: Hospital, Laboratory, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Grifols, Fortress Diagnostics, Ortho Clinical Diagnostics, ISLAB, Biorex Diagnostics, Bio-Rad, Tulip Diagnostics, KangJia, Aikang MedTech, Zhuhai Ideal Biotech, BSBE

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 109 pages
Market size 2025
$77.28
Million USD
Forecast CAGR
7%
2025-2032
Forecast 2032
$124.1
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Blood Grouping Gel Card market size is predicted to grow from US$ 77.28 million in 2025 to US$ 123 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

Blood Grouping Gel Card is a disposable card or device used in blood typing and blood grouping tests. The gel card method involves mixing a patient's blood sample with specific reagents and observing the agglutination patterns in the gel matrix to determine the blood group and compatibility for transfusion purposes.

Market Overview

Blood grouping gel cards are used in the process of ABO and Rh blood typing, which is crucial for ensuring the compatibility of blood donations with recipients during transfusions. The market for these gel cards is driven by several factors, including the increasing demand for safe blood transfusions, advancements in medical technology, and the global expansion of healthcare infrastructure.

Key Market Drivers

Rising Demand for Safe Blood Transfusions:

With the increasing incidence of diseases and accidents, the demand for blood transfusions has surged.

Ensuring the safety and compatibility of blood donations is paramount, which has led to a growing demand for blood grouping gel cards.

Advancements in Medical Technology:

Continuous improvements in diagnostic technologies have led to the development of more accurate and efficient blood grouping methods.

Gel cards are one such technology that offers rapid and reliable results, contributing to their growing popularity.

Global Expansion of Healthcare Infrastructure:

As healthcare infrastructure expands worldwide, more clinical laboratories and blood banks are being established.

This expansion has created a significant demand for blood grouping gel cards.

Market Challenges

Regulatory Hurdles:

The medical device industry is subject to stringent regulatory requirements.

Manufacturers of blood grouping gel cards must navigate complex regulatory landscapes to ensure their products meet safety and efficacy standards.

Conclusion

The Blood Grouping Gel Card market is a growing segment of the healthcare industry. Driven by factors such as the increasing demand for safe blood transfusions, advancements in medical technology, and the global expansion of healthcare infrastructure, this market is poised for significant growth. However, manufacturers must navigate regulatory hurdles and compete in a highly competitive landscape to succeed. As new blood typing technologies emerge, manufacturers will need to stay abreast of these developments to ensure their products remain relevant and competitive.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Grouping Gel Card market?

What factors are driving Blood Grouping Gel Card market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Grouping Gel Card market opportunities vary by end market size?

How does Blood Grouping Gel Card break out by Type, by Application?

This report presents a comprehensive overview of the global Blood Grouping Gel Card market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Six Columns
  • Eight Columns

Segment by Application

  • Hospital
  • Laboratory
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Grouping Gel Card market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Laboratory, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Blood Grouping Gel Card Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$77.28
2025
Forecast
$124.1
2032
CAGR
7%
2025–2032
Regiões
5
global
Key companies
GrifolsFortress DiagnosticsOrtho Clinical DiagnosticsISLABBiorex DiagnosticsBio-RadTulip DiagnosticsKangJia
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Six ColumnsEight Columns
By Application
HospitalLaboratoryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Six Columns
  • 3.1.3 Eight Columns
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Laboratory
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Grifols
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Fortress Diagnostics
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Ortho Clinical Diagnostics
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 ISLAB
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Biorex Diagnostics
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bio-Rad
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Tulip Diagnostics
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 KangJia
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Aikang MedTech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Zhuhai Ideal Biotech
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 BSBE
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Blood Grouping Gel Card market size?
The global Blood Grouping Gel Card market is estimated at US$ 77.28 million in 2025 (base year) and is projected to reach US$ 123 million by 2032.
What growth rate is expected for the Blood Grouping Gel Card market through 2032?
The market is expected to grow at a CAGR of 7.0% from 2026 to 2032, expanding from US$ 77.28 million in 2025 to US$ 123 million in 2032, roughly 1.6 times its base-year value.
How is Blood Grouping Gel Card defined?
Blood Grouping Gel Card is a disposable card or device used in blood typing and blood grouping tests. The gel card method involves mixing a patient's blood sample with specific reagents and observing the agglutination patterns in the gel matrix to determine the blood group and compatibility for transfusion purposes.
How is the Blood Grouping Gel Card market segmented by type?
By type, the market is segmented into Six Columns and Eight Columns.
What are the key applications of Blood Grouping Gel Card?
Key applications covered include Hospital, Laboratory and Others.
Which companies are profiled in the Blood Grouping Gel Card market report?
Key players profiled include Grifols, Fortress Diagnostics, Ortho Clinical Diagnostics, ISLAB, Biorex Diagnostics, Bio-Rad, Tulip Diagnostics and KangJia, among 11 companies covered in total.
What geographies does the Blood Grouping Gel Card market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Blood Grouping Gel Card?
The market for these gel cards is driven by several factors, including the increasing demand for safe blood transfusions, advancements in medical technology, and the global expansion of healthcare infrastructure.
Who should buy the Blood Grouping Gel Card market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Laboratory and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Blood Grouping Gel Card market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.